These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25380420)

  • 21. Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2.
    Guler SA; Lindell KO; Swigris J; Ryerson CJ
    Am J Respir Crit Care Med; 2021 Feb; 203(3):P7-P8. PubMed ID: 33522880
    [No Abstract]   [Full Text] [Related]  

  • 22. A new era of drug therapy for idiopathic pulmonary fibrosis.
    Crooks MG; Hart SP
    Lancet Respir Med; 2014 Dec; 2(12):964-6. PubMed ID: 25466348
    [No Abstract]   [Full Text] [Related]  

  • 23. New guideline on treatment of idiopathic pulmonary fibrosis.
    Spagnolo P; Bonella F; Maher TM
    Lancet Respir Med; 2015 Sep; 3(9):e31-e32. PubMed ID: 26380887
    [No Abstract]   [Full Text] [Related]  

  • 24. [Idiopathic pulmonary fibrosis: A new era, new challenges].
    Cottin V
    Rev Mal Respir; 2014 Sep; 31(7):583-6. PubMed ID: 25239578
    [No Abstract]   [Full Text] [Related]  

  • 25. Pirfenidone for idiopathic pulmonary fibrosis.
    Bouros D
    Lancet; 2011 May; 377(9779):1727-9. PubMed ID: 21571363
    [No Abstract]   [Full Text] [Related]  

  • 26. [How to face the current status of therapies for idiopathic pulmonary fibrosis].
    Zhang DP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):844-7. PubMed ID: 24507398
    [No Abstract]   [Full Text] [Related]  

  • 27. Naloxegol oxalate, pirfenidone, and nintedanib.
    Hussar DA; Jeon MM
    J Am Pharm Assoc (2003); 2015; 55(4):461-3. PubMed ID: 26161491
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological treatment of idiopathic pulmonary fibrosis: an update.
    Spagnolo P; Wells AU; Collard HR
    Drug Discov Today; 2015 May; 20(5):514-24. PubMed ID: 25613790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial research in focus: why do so many clinical trials fail in IPF?
    Spagnolo P; Maher TM
    Lancet Respir Med; 2017 May; 5(5):372-374. PubMed ID: 28412184
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues.
    Miller HI
    Mo Med; 2019; 116(3):168-169. PubMed ID: 31527930
    [No Abstract]   [Full Text] [Related]  

  • 31. Case 10-2019: A 69-Year-Old Man with Progressive Dyspnea.
    Black KE; Montesi SB; Feneis JF; Mark EJ
    N Engl J Med; 2019 Mar; 380(13):1268-1277. PubMed ID: 30917264
    [No Abstract]   [Full Text] [Related]  

  • 32. Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.
    Milger K; Kneidinger N; Neurohr C; Reichenberger F; Behr J
    Eur Respir J; 2015 Oct; 46(4):1217-21. PubMed ID: 26341986
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatments for idiopathic pulmonary fibrosis.
    Koczulla AR
    N Engl J Med; 2014 Aug; 371(8):781. PubMed ID: 25140968
    [No Abstract]   [Full Text] [Related]  

  • 34. Idiopathic Pulmonary Fibrosis.
    Lederer DJ; Martinez FJ
    N Engl J Med; 2018 May; 378(19):1811-1823. PubMed ID: 29742380
    [No Abstract]   [Full Text] [Related]  

  • 35. New era of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Respir Investig; 2018 Nov; 56(6):427-429. PubMed ID: 30366836
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in understanding of idiopathic pulmonary fibrosis.
    Wang ZL
    Chin Med J (Engl); 2009 Apr; 122(7):844-57. PubMed ID: 19493401
    [No Abstract]   [Full Text] [Related]  

  • 37. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
    Azuma A
    Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "The Long and Winding Road" seeking specific drugs for idiopathic pulmonary fibrosis.
    Munakata M
    Respir Investig; 2016 Jan; 54(1):1. PubMed ID: 26718137
    [No Abstract]   [Full Text] [Related]  

  • 39. Galecto Biotech.
    Garber K
    Nat Biotechnol; 2013 Jun; 31(6):481. PubMed ID: 23752421
    [No Abstract]   [Full Text] [Related]  

  • 40. A new hope for idiopathic pulmonary fibrosis.
    Hunninghake GM
    N Engl J Med; 2014 May; 370(22):2142-3. PubMed ID: 24836311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.